The same research suggests that 22% of patients given methotrexate discontinue usage because of gastrointestinal side effects such as diarrhea.Prior to an injectable drug shortage which started in 2009 and has continued, parenteral methotrexate administration accounted for 8% of methotrexate prescriptions.